| Lakefront Wellness Center, Sc | |
|
161 W Wisconsin Ave Ste 2b Pewaukee WI 53072-3468 | |
| (262) 695-8857 | |
| (262) 695-8879 |
| Full Name | Lakefront Wellness Center, Sc |
|---|---|
| Speciality | Psychologist |
| Location | 161 W Wisconsin Ave Ste 2b, Pewaukee, Wisconsin |
| Authorized Official Name and Position | Beth A. Johnson (DIRECTOR) |
| Authorized Official Contact | 2626958857 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Lakefront Wellness Center, Sc 161 W Wisconsin Ave Ste 2b Pewaukee WI 53072-3468 Ph: (262) 695-8857 | Lakefront Wellness Center, Sc 161 W Wisconsin Ave Ste 2b Pewaukee WI 53072-3468 Ph: (262) 695-8857 |
| NPI Number | 1316024847 |
|---|---|
| Provider Enumeration Date | 11/01/2006 |
| Last Update Date | 08/27/2013 |
| Medicare PECOS PAC ID | 5193719334 |
|---|---|
| Medicare Enrollment ID | O20040412000962 |
News Archive
With Election Day less than a month away, a new West Health-Gallup national survey finds more Americans trust former Vice President Joe Biden than President Donald Trump to efficiently lead the U.S. healthcare system through the COVID-19 pandemic.
People in treatment for opioid addiction are more likely to relapse when they become more tolerant of risks, according to a study by Rutgers and other institutions. The findings can help clinicians better predict which patients are most vulnerable.
High blood sugar may increase the risk of pancreatic cancer, according to a study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
President Barack Obama's health care law would expand the number of people on Medicaid by raising the income ceiling for eligibility, but some states aren't so sure they want to participate because they are worried they might not be able to ultimately put up their share of funding.
PharmaDirections congratulates Orexigen Therapeutics on achieving FDA Advisory Board approval for their anti-obesity drug Contrave™. PharmaDirections is proud to have been Orexigen's pharmaceutical development partner and to have developed and produced the first Contrave™ product to undergo full clinical development.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316024847 | NPI | - | NPPES |
| 42230900 | Medicaid | WI |
| Provider Name | Kim M Gorecki |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1649361775 PECOS PAC ID: 8426062142 Enrollment ID: I20060202000277 |
News Archive
With Election Day less than a month away, a new West Health-Gallup national survey finds more Americans trust former Vice President Joe Biden than President Donald Trump to efficiently lead the U.S. healthcare system through the COVID-19 pandemic.
People in treatment for opioid addiction are more likely to relapse when they become more tolerant of risks, according to a study by Rutgers and other institutions. The findings can help clinicians better predict which patients are most vulnerable.
High blood sugar may increase the risk of pancreatic cancer, according to a study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
President Barack Obama's health care law would expand the number of people on Medicaid by raising the income ceiling for eligibility, but some states aren't so sure they want to participate because they are worried they might not be able to ultimately put up their share of funding.
PharmaDirections congratulates Orexigen Therapeutics on achieving FDA Advisory Board approval for their anti-obesity drug Contrave™. PharmaDirections is proud to have been Orexigen's pharmaceutical development partner and to have developed and produced the first Contrave™ product to undergo full clinical development.
› Verified 9 days ago
| Provider Name | Beth A Johnson |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1811925613 PECOS PAC ID: 6608860853 Enrollment ID: I20060302000696 |
News Archive
With Election Day less than a month away, a new West Health-Gallup national survey finds more Americans trust former Vice President Joe Biden than President Donald Trump to efficiently lead the U.S. healthcare system through the COVID-19 pandemic.
People in treatment for opioid addiction are more likely to relapse when they become more tolerant of risks, according to a study by Rutgers and other institutions. The findings can help clinicians better predict which patients are most vulnerable.
High blood sugar may increase the risk of pancreatic cancer, according to a study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
President Barack Obama's health care law would expand the number of people on Medicaid by raising the income ceiling for eligibility, but some states aren't so sure they want to participate because they are worried they might not be able to ultimately put up their share of funding.
PharmaDirections congratulates Orexigen Therapeutics on achieving FDA Advisory Board approval for their anti-obesity drug Contrave™. PharmaDirections is proud to have been Orexigen's pharmaceutical development partner and to have developed and produced the first Contrave™ product to undergo full clinical development.
› Verified 9 days ago
News Archive
With Election Day less than a month away, a new West Health-Gallup national survey finds more Americans trust former Vice President Joe Biden than President Donald Trump to efficiently lead the U.S. healthcare system through the COVID-19 pandemic.
People in treatment for opioid addiction are more likely to relapse when they become more tolerant of risks, according to a study by Rutgers and other institutions. The findings can help clinicians better predict which patients are most vulnerable.
High blood sugar may increase the risk of pancreatic cancer, according to a study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
President Barack Obama's health care law would expand the number of people on Medicaid by raising the income ceiling for eligibility, but some states aren't so sure they want to participate because they are worried they might not be able to ultimately put up their share of funding.
PharmaDirections congratulates Orexigen Therapeutics on achieving FDA Advisory Board approval for their anti-obesity drug Contrave™. PharmaDirections is proud to have been Orexigen's pharmaceutical development partner and to have developed and produced the first Contrave™ product to undergo full clinical development.
› Verified 9 days ago
Thundermist, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2108a Silvernail Rd, Suite 116, Pewaukee, WI 53072 Phone: 888-468-9981 | |
Raclaw Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: N27w23960 Paul Rd Ste 5, Pewaukee, WI 53072 Phone: 414-367-8070 | |
Alay Health Team Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2351 Silvernail Rd, Pewaukee, WI 53072 Phone: 262-260-9000 Fax: 262-260-9109 | |
Barbara C Sieck Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 325 Forest Grove Dr, Suite 201, Pewaukee, WI 53072 Phone: 262-899-2106 | |
Community Medical Services Pewaukee Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1611 Silvernail Rd, Pewaukee, WI 53072 Phone: 262-304-0150 Fax: 262-933-4244 | |
Pediatric Neuropsychology And Treatment Associates, Sc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: N27w23953 Paul Rd, Ste. 206, Pewaukee, WI 53072 Phone: 262-347-0701 Fax: 262-347-0705 |